Chemomab Therapeutics
(NASDAQ) CMMB
Chemomab Therapeutics Financials at a Glance
Market Cap
$10.96M
Revenue (TTM)
$0.00
Net Income (TTM)
$10.09M
EPS (TTM)
$-1.47
P/E Ratio
-1.21
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Price
$1.73
Volume
730
Open
$1.78
Price
$1.73
Volume
730
Open
$1.78
Previous Close
$1.73
Daily Range
$1.71 - $1.79
52-Week Range
$1.35 - $5.88
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Price
$1.73
Volume
730
Open
$1.78
Previous Close
$1.73
Daily Range
$1.71 - $1.79
52-Week Range
$1.35 - $5.88
CMMB News
CMMB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Chemomab Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
16
CEO
Adi Mor, PhD
Website
www.chemomab.comHeadquarters
Tel Aviv, 6158002, IL
CMMB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-70%
Return on Capital
-96%
Return on Assets
-82%
Earnings Yield
-82.64%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.96M
Shares Outstanding
6.16M
Volume
730
Short Interest
0.00%
Avg. Volume
82.44K
Financials (TTM)
Gross Profit
$53.25K
Operating Income
$14.74M
EBITDA
$13.96M
Operating Cash Flow
$15.46M
Capital Expenditure
$4.96
Free Cash Flow
$15.46M
Cash & ST Invst.
$14.27M
Total Debt
$324.00K
Chemomab Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$10.96M
N/A
Market Cap/Employee
$547.80K
N/A
Employees
20
N/A
Net Income
$1.74M
+50.0%
EBITDA
$1.84M
+50.1%
Quarterly Fundamentals
Net Cash
$10.06M
-47.2%
Accounts Receivable
$1.72M
+292.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-81.54%
N/A
Return on Invested Capital
-96.22%
N/A
Free Cash Flow
$0.00
N/A
Operating Cash Flow
$0.00
N/A